RedHill Biopharma Ltd (RDHL) has released an update.
RedHill Biopharma Ltd. has postponed its Extraordinary General Meeting of Shareholders originally scheduled for March 20, 2024, due to the absence of a legal quorum. The meeting is rescheduled to take place on March 21, 2024, at the company’s headquarters in Tel Aviv, Israel. This announcement was made in compliance with SEC regulations and affects the company’s various registration statements.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
